Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 199.20

+0.1%

Nov 21 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: WTDEC who wrote (29976)	1/8/2000 4:58:00 PM
From: Henry Niman	Read Replies (1) of 32384

Yes Walter, many saw their quality of life improve, even if they didn't make pre-defined cut-off on the changes in the lesions. The FDA deserves credit for seeing that all of the patients stood a reasonable chance of benefiting, and approved the drug for early and late stage patients. What I find most amazing is the fact that two members voted against approval, even for advance patients! The FDA Modernization Act included use of tumor shrinkage as a method for demonstrating efficacy, and I think that all members agreed that LGND had demonstrated that benefit, so it seems that the approval rec should have been unanimous for early and late stage patients.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next